RGEN: הכנסות ממכירות החברה repligen.com
Geopolitical fragmentation is hindering the export of precision bio-equipment and blocking the supply of consumables. Repligen Corporation (RGEN) sales volumes clearly demonstrate these risks, while the value of 0.81 reflects the metric's balance. The scientific community's high level of trust in RGEN technologies, combined with the gradual overcoming of the destocking phase, creates a foundation for long-term growth in the gene therapy segment.
%20%D7%94%D7%9B%D7%A0%D7%A1%D7%95%D7%AA%20%D7%95%D7%A0%D7%A4%D7%97%20%D7%9E%D7%9B%D7%99%D7%A8%D7%95%D7%AA&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_RGEN_-_Repligen-Corporation_-_Revenue-and-Sales-Volume "RGEN: מכירות החברה Repligen Corp. 04.07.2022 - 13.11.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת Repligen Corporation
Repligen Corporation (RGEN) provides high-tech delivery of biofiltration systems for the pharmaceutical industry, where logistical precision directly determines commercial success. The daily trading volume reflected in the company's sales statistics on GURU.Markets measures current liquidity and operational activity, allowing investors to assess the business's financial stability and promptly identify risks of a deep portfolio drawdown.
